Wellington Management Group’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$853K Sell
127,543
-13,416
-10% -$77K ﹤0.01% 1706
2025
Q4
$768K Buy
140,959
+13,647
+11% +$81K ﹤0.01% 1762
2025
Q3
$787K Sell
127,312
-62,173
-33% -$407K ﹤0.01% 1821
2025
Q2
$1.19M Buy
189,485
+50,533
+36% +$296K ﹤0.01% 1690
2025
Q1
$814K Buy
138,952
+7,898
+6% +$59.8K ﹤0.01% 1749
2024
Q4
$1.08M Buy
131,054
+14,662
+13% +$138K ﹤0.01% 1701
2024
Q3
$1.04M Buy
+116,392
New +$998K ﹤0.01% 1704

Other funds holding AURA

Wellington Management Group's AURA Position: Q1 2026 in Review

Wellington Management Group reduced its Aura Biosciences (AURA) stake by 9.5% in Q1 2026, selling an estimated $77K and leaving 127,543 shares worth $853K. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

Wellington Management Group first reported a position in AURA in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.19M in Q2 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Wellington Management Group held 127,543 shares of Aura Biosciences worth $853K as of Q1 2026.
  • Wellington Management Group sold 13,416 Aura Biosciences shares in Q1 2026, an estimated $77K.
  • Aura Biosciences made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1706 holding.
  • Wellington Management Group first reported a position in Aura Biosciences in Q3 2024 and has held it in 7 quarters since.
  • Wellington Management Group's Aura Biosciences position peaked at $1.19M in Q2 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.